Drug Profile
Influenza vaccine - Scinai Immunotherapeutics
Alternative Names: BVX-M001; M 001; Multimeric Multi-Epitope Polypeptide Influenza Vaccine; Multimeric-001; Multimeric-001 Universal Flu Vaccine - Scinai Immunotherapeutics; Universal Flu Vaccine - Scinai ImmunotherapeuticsLatest Information Update: 11 Sep 2023
Price :
$50
*
At a glance
- Originator Weizmann Institute of Science
- Developer National Institutes of Health; Scinai Immunotherapeutics
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Influenza virus infections